Abstract
This study evaluated the effects of alloxan on the kinetics properties of the δ-aminolevulinate dehydratase (δ-ALA-D) using mouse liver homogenates. δ-ALA-D is an important sulfhydryl enzyme that catalyses the second step in heme biosynthesis and is commonly diminished in experimental and human diabetes. Despite the known effects of alloxan in models of experimental diabetes, there are no data in the literature demonstrating the effects of alloxan on the kinetics properties of the δ-ALA-D. The results showed that alloxan (1.25–20 μM) caused a concentration-dependent inhibition of hepatic δ-ALA-D activity. The inhibition constant (K i ) for alloxan-induced inhibition on δ-ALA-D was 3.64 μM. The alloxan (5 μM) caused a decrease in V max (65.8%) and in K m (53.1%), which is suggestive of an uncompetitive inhibition of enzyme. In addition, dithiothreitol (700 and 1,000 μM) completely prevented the δ-ALA-D activity inhibition induced by 10 and 20 μM alloxan. Similar protection was obtained in the presence of 2,000 μM glutathione. Therefore, this work showed that the inhibition of hepatic δ-ALA-D activity can be obtained in vitro at low micromolar levels of alloxan, and can also be prevented by reducing agents. Moreover, these results may help to understand the abnormalities in heme pathway found in models of experimental diabetes in vivo.
Similar content being viewed by others
References
Sassa, S. (1998). Seminars in Liver Disease, 18, 5–101.
Sterling, K., Silver, M., & Ricketts, H. T. (1949). Archives of Internal Medicine, 84, 965–975.
Burnham, T. K., & Fosnaugh, R. P. (1961). Archives of Dermatology, 83, 717–722.
Stein, J. A., & Tschudy, D. P. (1970). Medicine (Baltimore), 49, 1–16.
Goerz, G., & Korda, S. (1977). Zeits Hautkrank, 52, 1165–1174.
Székely, E., Bor, M., Tasnádi, G., Várnai, K., Almási, A., & Blázovic, A. (2006). Clinical Hemorheology and Microcirculation, 35, 387–396.
Grossman, M. E., Bickers, D. R., Poh-Fitzpatrick, M. B., Deleo, V. A., & Harber, L. C. (1979). American Journal of Medicine, 67, 277–286.
Lisi, P., Santeusanio, F., & Lombardi, G. (1983). Dermatologica, 166, 287–293.
Sibbald, R. G., & Schachter, R. K. (1984). International Journal of Dermatology, 23, 567–584.
Mengistu, M. (1987). Tropical and Geographical Medicine, 39, 361–365.
Magnin, P. H., & Lenczner, J. M. (1990). Argentina de Dermatolologia, 71, 45–47.
Santamaría, V. G., & Barrios, E. G. (2001). Revista del Centro Dermatológico Pascua, 10, 1–12.
Caballero, F. A., Gerez, E. N., Polo, C. F., Vazquez, E. S., & Batlle, A. M. C. (1998). General Pharmacology, 31, 441–445.
Folmer, V., Soares, J. C. M., & Rocha, J. B. T. (2002). International Journal of Biochemistry and Cell Biology, 34, 1279–1285.
Folmer, V., Soares, J. C. M., Gabriel, D., & Rocha, J. B. T. (2003). Journal of Nutrition, 133, 2165–2170.
Brito, V. B., Folmer, V., Soares, J. C., Silveira, I. D., & Rocha, J. B. (2007). Nutrition, 23, 818–826.
Brito, V. B., da Rocha, J. B. T., Puntel, G. O., da Luz, S. C. A., Barbosa, N. B. V., de Carvalho, N. R., et al. (2011). Experimental and Toxicologic Pathology, 63, 443–451.
Sassa, S. (1982). Enzyme, 28, 133–145.
Shemim, D. (1976). Philosophical Transactions of the Royal Society of London, Series B, 273, 109–115.
Tsukamoto, I., Yoshinaga, T., & Sano, S. (1979). Biochimica et Biophysica Acta, 570, 167–178.
Farina, M., Brandão, R., Lara, F. S., Soares, F. A., Souza, D. O., & Rocha, J. B. T. (2003). Toxicology Letters, 139, 55–66.
Perottoni, J., Meotti, F. C., Folmer, V., Pivetta, L., Nogueira, C. W., Zeni, G., et al. (2005). Environmental Toxicology and Pharmacology, 19, 239–248.
Spencer, P., & Jordan, P. M. (1994). Biochemical Journal, 300, 373–381.
Spencer, P., & Jordan, P. M. (1995). Biochemical Journal, 305, 151–158.
Valentini, J., Grotto, D., Paniz, C., Roehrs, M., Burg, G., & Garcia, S. C. (2008). Biomedicine & Pharmacotherapy, 62, 378–382.
Dunn, J. S., Sheehan, H. L., & McLetchie, N. G. B. (1943). Lancet, 1, 484–487.
Lenzen, S., & Panten, U. (1988). Diabetologia, 31, 337–342.
Grankvist, K., Marklund, S. L., Sehlin, J., & Taljedal, I. B. (1979). Biochemical Journal, 182, 17–25.
Nukatsuka, M., Sakurai, H., & Kawada, J. (1989). Biochemical and Biophysical Research Communications, 165, 278–283.
Elsner, M., Gurgul-Convey, E., & Lenzen, S. (2008). Antioxidants and Redox Signaling, 10, 691–699.
Lenzen, S. (2008). Diabetologia, 51, 216–226.
Munday, R. (1988). Biochemical Pharmacology, 37, 409–413.
Elsner, M., Gurgul-Convey, E., & Lenzen, S. (2006). Free Radical Biology and Medicine, 41, 825–834.
Winterbourn, C. C., & Munday, R. (1989). Biochemical Pharmacology, 38, 271–277.
Ammon, H. P., & Mark, M. (1985). Cell Biochemistry Function, 3, 157–171.
Boquist, L., & Ericsson, I. (1984). FEBS Letters, 178, 245–248.
Tiedge, M., Krug, U., & Lenzen, S. (1997). Biochimica et Biophysica Acta, 1337, 175–190.
Zhang, X., Liang, W., Mao, Y., Li, H., Yang, Y., & Tan, H. (2009). Biomedicine & Pharmacotherapy, 63, 180–186.
Barbosa, N. B., Rocha, J. B. T., Zeni, G., Emanuelli, T., Beque, M. C., & Braga, A. L. (1998). Toxicology and Applied Pharmacology, 149, 243–253.
Bradford, M. M. (1976). Analytical Biochemistry, 72, 248–254.
Elsner, M., Tiedge, M., Guldbakke, B., Munday, R., & Lenzen, S. (2002). Diabetologia, 45, 1542–1549.
Leech, R., & Bailey, C. (1945). Journal of Biological Chemistry, 157, 525–542.
Bruckmann, G., & Wertheimer, E. (1947). Journal of Biological Chemistry, 168, 241–256.
Bhattacharya, S. K., Robson, J. S., & Stewart, C. P. (1956). Biochemical Journal, 62, 12–21.
Kiersztan, A., Baranska, A., Hapka, M., Lebiedzinska, M., Winiarska, K., Dudziak, M., et al. (2009). Chemico-Biological Interactions, 177, 161–171.
Szkudelski, T., Kandulska, K., & Okulicz, M. (1998). Physiological Research, 47, 343–346.
Grankvist, K., & Marklund, S. L. (1986). International Journal of Biochemistry, 18, 109–113.
Zhang, H., Gao, G., & Brunk, U. T. (1992). Acta Pathologica Microbiologica et Immunologica Scandinavica, 100, 317–325.
Patterson, J. W., Lazarow, A., & Levey, S. (1949). Journal of Biological Chemistry, 177, 197–204.
Caballero, F., Gerez, E., Pólo, C., Mompo, O., Vázquez, E., Schultz, R., et al. (1995). Medicina (Buenos Aires), 55, 117–124.
Czyzyk, A., & Gregor, A. (1971). Diabetologia, 152, 152–155.
Bitar, M., & Weiner, M. (1984). Diabetes, 33, 37–44.
Djordjevic, V. (1985). Archives Internationales de Physiologie et de Biochimie, 93, 285–290.
Mohamed, A. K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, R., & Nawroth, P. P. (1999). Biofactors, 10, 157–167.
Wolff, S. P., & Dean, R. T. (1987). Biochemical Journal, 245, 243–250.
Fernández-Cuartero, B., Rebollar, J. L., Batlle, A., & Salamanca, R. E. (1999). International Journal of Biochemistry and Cell Biology, 31, 479–488.
Tippett, P. S., & Neet, K. E. (1983). Archives of Biochemistry and Biophysics, 222, 285–298.
Lazarow, A. (1949). Physiological Reviews, 29, 48–74.
Acknowledgements
This study was supported by FAPERGS (Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul), CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brito, V.B., Folmer, V., Guerra, I.I.R. et al. Kinetics of Alloxan-Induced Inhibition on δ-Aminolevulinate Dehydratase Activity in Mouse Liver Homogenates. Appl Biochem Biotechnol 166, 1047–1056 (2012). https://doi.org/10.1007/s12010-011-9492-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-011-9492-8